![](/images/general/no_picture/200_user.png)
Brant T Bennett
Examiner (ID: 9315)
Most Active Art Unit | 3786 |
Art Unit(s) | 3786 |
Total Applications | 35 |
Issued Applications | 11 |
Pending Applications | 0 |
Abandoned Applications | 24 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18399312
[patent_doc_number] => 11661438
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Purification of antibody drug conjugates using a sodium phosphate gradient
[patent_app_type] => utility
[patent_app_number] => 15/778290
[patent_app_country] => US
[patent_app_date] => 2016-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9024
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778290
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/778290 | Purification of antibody drug conjugates using a sodium phosphate gradient | Dec 6, 2016 | Issued |
Array
(
[id] => 13552511
[patent_doc_number] => 20180327803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => SEPARATING AGENT FOR HUMAN SERUM-DERIVED IgG POLYCLONAL ANTIBODIES, AND METHOD FOR SEPARATING HUMAN SERUM-DERIVED IgG POLYCLONAL ANTIBODIES USING SAME
[patent_app_type] => utility
[patent_app_number] => 15/774398
[patent_app_country] => US
[patent_app_date] => 2016-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15774398
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/774398 | Separating agent for human serum-derived IgG polyclonal antibodies, and method for separating human serum-derived IgG polyclonal antibodies using same | Nov 6, 2016 | Issued |
Array
(
[id] => 11443190
[patent_doc_number] => 20170044211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'Wash solution comprising arginine for the affinity chromatography step in antibody purification'
[patent_app_type] => utility
[patent_app_number] => 15/336878
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10563
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15336878
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/336878 | Wash solution comprising arginine for the affinity chromatography step in antibody purification | Oct 27, 2016 | Abandoned |
Array
(
[id] => 13551799
[patent_doc_number] => 20180327447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => IMPROVED PROTEIN SEPARATION IN ION EXCHANGE CHROMATOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 15/776941
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15776941
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/776941 | IMPROVED PROTEIN SEPARATION IN ION EXCHANGE CHROMATOGRAPHY | Oct 27, 2016 | Abandoned |
Array
(
[id] => 13507717
[patent_doc_number] => 20180305401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => PROCESSES FOR PURIFYING PROTEINS FROM PLASMA
[patent_app_type] => utility
[patent_app_number] => 15/770111
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -81
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15770111
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/770111 | PROCESSES FOR PURIFYING PROTEINS FROM PLASMA | Oct 20, 2016 | Abandoned |
Array
(
[id] => 13507743
[patent_doc_number] => 20180305414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => IMMUNOGLOBULIN-BINDING POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 15/770150
[patent_app_country] => US
[patent_app_date] => 2016-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 1176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15770150
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/770150 | Immunoglobulin-binding polypeptide | Oct 18, 2016 | Issued |
Array
(
[id] => 11844605
[patent_doc_number] => 09732149
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-15
[patent_title] => 'Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement'
[patent_app_type] => utility
[patent_app_number] => 15/284015
[patent_app_country] => US
[patent_app_date] => 2016-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16136
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15284015
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/284015 | Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement | Oct 2, 2016 | Issued |
Array
(
[id] => 11395205
[patent_doc_number] => 20170015740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'METHODS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/282464
[patent_app_country] => US
[patent_app_date] => 2016-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38927
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15282464
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/282464 | METHODS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS | Sep 29, 2016 | Abandoned |
Array
(
[id] => 14611553
[patent_doc_number] => 10358462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-23
[patent_title] => Method for the preparation of immunoglobulins
[patent_app_type] => utility
[patent_app_number] => 15/276544
[patent_app_country] => US
[patent_app_date] => 2016-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11978
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15276544
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/276544 | Method for the preparation of immunoglobulins | Sep 25, 2016 | Issued |
Array
(
[id] => 16253492
[patent_doc_number] => 20200262866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => PROCESS OF MANUFACTURE OF ANNEXIN V
[patent_app_type] => utility
[patent_app_number] => 15/760641
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -58
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760641
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760641 | Process of manufacture of annexin V | Sep 15, 2016 | Issued |
Array
(
[id] => 11828771
[patent_doc_number] => 09725504
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-08
[patent_title] => 'Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement'
[patent_app_type] => utility
[patent_app_number] => 15/260888
[patent_app_country] => US
[patent_app_date] => 2016-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16112
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15260888
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/260888 | Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement | Sep 8, 2016 | Issued |
Array
(
[id] => 11336721
[patent_doc_number] => 20160362477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'SECRETORY IGA COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/249811
[patent_app_country] => US
[patent_app_date] => 2016-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6042
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15249811
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/249811 | Secretory IgA compositions, methods of making and methods of use thereof | Aug 28, 2016 | Issued |
Array
(
[id] => 11324967
[patent_doc_number] => 20160355579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'METHODS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/243290
[patent_app_country] => US
[patent_app_date] => 2016-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39001
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15243290
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/243290 | Methods for treating complement-associated disorders | Aug 21, 2016 | Issued |
Array
(
[id] => 11324969
[patent_doc_number] => 20160355580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'METHODS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/243386
[patent_app_country] => US
[patent_app_date] => 2016-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38996
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15243386
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/243386 | METHODS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS | Aug 21, 2016 | Abandoned |
Array
(
[id] => 13357281
[patent_doc_number] => 20180230180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => Charged Depth Filtration of Antigen-Binding Proteins
[patent_app_type] => utility
[patent_app_number] => 15/751231
[patent_app_country] => US
[patent_app_date] => 2016-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15751231
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/751231 | Charged depth filtration of antigen-binding proteins | Aug 11, 2016 | Issued |
Array
(
[id] => 13793299
[patent_doc_number] => 20190010188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => METHOD FOR PURIFYING COMPOSITION COMPRISING ANTIBODIES WITH ANIONIC POLYMER
[patent_app_type] => utility
[patent_app_number] => 15/748736
[patent_app_country] => US
[patent_app_date] => 2016-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748736
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748736 | Method for purifying composition comprising antibodies with anionic polymer | Jul 28, 2016 | Issued |
Array
(
[id] => 13342799
[patent_doc_number] => 20180222939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => AFFINITY SUPPORT AND METHOD FOR ISOLATING IMMUNOGLOBULIN
[patent_app_type] => utility
[patent_app_number] => 15/745855
[patent_app_country] => US
[patent_app_date] => 2016-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8352
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745855
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/745855 | Affinity support and method for isolating immunoglobulin | Jul 26, 2016 | Issued |
Array
(
[id] => 11395167
[patent_doc_number] => 20170015702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-19
[patent_title] => 'OPTIMIZED METHOD FOR ANTIBODY CAPTURING BY MIXED MODE CHROMATOGRAPHY'
[patent_app_type] => utility
[patent_app_number] => 15/216099
[patent_app_country] => US
[patent_app_date] => 2016-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4930
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15216099
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/216099 | Optimized method for antibody capturing by mixed mode chromatography | Jul 20, 2016 | Issued |
Array
(
[id] => 16383220
[patent_doc_number] => 10808042
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Immunoglobulin-binding proteins and their use in affinity purification
[patent_app_type] => utility
[patent_app_number] => 15/744147
[patent_app_country] => US
[patent_app_date] => 2016-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 16
[patent_no_of_words] => 13365
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15744147
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/744147 | Immunoglobulin-binding proteins and their use in affinity purification | Jul 13, 2016 | Issued |
Array
(
[id] => 16634468
[patent_doc_number] => 10912955
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-09
[patent_title] => Treatment of celiac disease, C. difficile infection, food intolerance and food allergy with secretory IgA/IgM
[patent_app_type] => utility
[patent_app_number] => 15/205359
[patent_app_country] => US
[patent_app_date] => 2016-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9318
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15205359
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/205359 | Treatment of celiac disease, C. difficile infection, food intolerance and food allergy with secretory IgA/IgM | Jul 7, 2016 | Issued |